These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6813008)

  • 1. Functional properties of anti-group B streptococcal monoclonal antibodies.
    Harris MC; Douglas SD; Kolski GB; Polin RA
    Clin Immunol Immunopathol; 1982 Sep; 24(3):342-50. PubMed ID: 6813008
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody to streptococcal group B carbohydrate: applications in latex agglutination and immunoprecipitin assays.
    Ruch FE; Smith L
    J Clin Microbiol; 1982 Jul; 16(1):145-52. PubMed ID: 6809789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Precipitating monoclonal antibodies to 1 of the antigenic determinants of streptococcal group-A polysaccharide].
    Drobyshevskaia EI; Borodiiuk NA; Kolesnikova VIu; Liampert IM
    Biull Eksp Biol Med; 1986 Mar; 101(3):339-41. PubMed ID: 2420393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus.
    Ricci ML; von Hunolstein C; Gomez MJ; Parisi L; Tissi L; Orefici G
    J Med Microbiol; 1996 Jun; 44(6):475-81. PubMed ID: 8636965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of hybridomas synthesizing monoclonal antibodies to streptococcal group A polysaccharide].
    Pyt'eva EIu; Drobyshevskaia EI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):35-9. PubMed ID: 3931394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of neonatal group B streptococcal infections.
    Baltimore RS
    Yale J Biol Med; 1982; 55(3-4):291-5. PubMed ID: 6758375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of group B streptococcal opsonins by radiolabeled bacterial uptake.
    Allred CD; Shigeoka AO; Hill HR
    J Immunol Methods; 1979; 26(4):355-63. PubMed ID: 379227
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies against the common polysaccharide of Streptococcus agalactiae.
    Rosocha J; Mikula I; Kollárová Z; Holoda E
    Folia Microbiol (Praha); 1996; 41(5):436-40. PubMed ID: 9131799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain differences in virulence of group B streptococci.
    Santos JI; Shigeoka AO; Hill HR
    Pediatr Res; 1982 May; 16(5):347-50. PubMed ID: 7048229
    [No Abstract]   [Full Text] [Related]  

  • 10. Group-B streptococcus--profile of an organism.
    Ross PW
    J Med Microbiol; 1984 Oct; 18(2):139-66. PubMed ID: 6387125
    [No Abstract]   [Full Text] [Related]  

  • 11. Group B streptococcus type II antisera have anti-galactan specificities.
    Uhlenbruck G; Lütticken R; Böhmer G; Janssen E; Pulverer G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):179-87. PubMed ID: 3925659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection.
    Shigeoka AO; Weber ME; Pincus SH; Pritchard DG; Egan ML; Hill HR
    J Infect Dis; 1986 Jun; 153(6):1170-3. PubMed ID: 3517190
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.
    Matsubara K; Katayama K; Baba K; Nigami H; Harigaya H
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):453-4. PubMed ID: 12827529
    [No Abstract]   [Full Text] [Related]  

  • 14. The soluble antigens of GBS as human vaccines.
    Swenson RM; Eisenstein TK; Shockman GD
    Antibiot Chemother (1971); 1985; 35():291-5. PubMed ID: 3901905
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
    Baker CJ; Rench MA; Kasper DL
    N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Streptococci group B in human pathology].
    Bulgakova TN; Grabovskaia KB; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):7-17. PubMed ID: 6314711
    [No Abstract]   [Full Text] [Related]  

  • 17. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
    Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
    Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial of screening test for prevention of neonatal infection due to group B Streptococcus].
    Suzuki Y; Hoshina K; Ito T; Amano Y; Onogawa T
    Kansenshogaku Zasshi; 1988 Oct; 62(10):911-5. PubMed ID: 3145313
    [No Abstract]   [Full Text] [Related]  

  • 19. Virulence of strains of new types and type candidates of group B streptococci (Streptococcus agalactiae). Comparative evaluation using mice and a chicken embryo model.
    Wagner M; Kaatz M
    Adv Exp Med Biol; 1997; 418():819-21. PubMed ID: 9331778
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of complement in opsonization of GBS.
    Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
    Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.